nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0857	0.38	CbGbCtD
Rufinamide—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0419	0.186	CbGbCtD
Rufinamide—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0333	0.215	CbGeAlD
Rufinamide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0325	0.144	CbGbCtD
Rufinamide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0302	0.134	CbGbCtD
Rufinamide—GRM5—ganglion—peripheral nervous system neoplasm	0.0185	0.119	CbGeAlD
Rufinamide—SCN11A—nerve—peripheral nervous system neoplasm	0.0139	0.0897	CbGeAlD
Rufinamide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0139	0.0615	CbGbCtD
Rufinamide—SCN11A—ganglion—peripheral nervous system neoplasm	0.0137	0.0886	CbGeAlD
Rufinamide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0127	0.0563	CbGbCtD
Rufinamide—SCN8A—nerve—peripheral nervous system neoplasm	0.0105	0.068	CbGeAlD
Rufinamide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00866	0.0384	CbGbCtD
Rufinamide—GRM5—brainstem—peripheral nervous system neoplasm	0.00803	0.0519	CbGeAlD
Rufinamide—SCN10A—nerve—peripheral nervous system neoplasm	0.00704	0.0455	CbGeAlD
Rufinamide—SCN10A—ganglion—peripheral nervous system neoplasm	0.00695	0.0449	CbGeAlD
Rufinamide—SCN11A—trigeminal ganglion—peripheral nervous system neoplasm	0.00673	0.0435	CbGeAlD
Rufinamide—SCN7A—trigeminal ganglion—peripheral nervous system neoplasm	0.00573	0.037	CbGeAlD
Rufinamide—SCN8A—brainstem—peripheral nervous system neoplasm	0.00452	0.0292	CbGeAlD
Rufinamide—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.00449	0.029	CbGeAlD
Rufinamide—GRM5—cerebellum—peripheral nervous system neoplasm	0.00396	0.0256	CbGeAlD
Rufinamide—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00341	0.0221	CbGeAlD
Rufinamide—SCN1A—brainstem—peripheral nervous system neoplasm	0.00341	0.0221	CbGeAlD
Rufinamide—SCN2A—brainstem—peripheral nervous system neoplasm	0.00313	0.0202	CbGeAlD
Rufinamide—SCN8A—cerebellum—peripheral nervous system neoplasm	0.00223	0.0144	CbGeAlD
Rufinamide—SCN1A—cerebellum—peripheral nervous system neoplasm	0.00168	0.0109	CbGeAlD
Rufinamide—SCN2A—cerebellum—peripheral nervous system neoplasm	0.00155	0.00998	CbGeAlD
Rufinamide—SCN3A—cerebellum—peripheral nervous system neoplasm	0.00136	0.00877	CbGeAlD
Rufinamide—SCN7A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00113	0.00605	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00109	0.00583	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.00107	0.00574	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00104	0.00558	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.00101	0.00545	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.001	0.0054	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000998	0.00536	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000998	0.00536	CbGpPWpGaD
Rufinamide—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000964	0.00518	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000962	0.00517	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000962	0.00517	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000948	0.00509	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000919	0.00494	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000906	0.00486	CbGpPWpGaD
Rufinamide—CES1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000903	0.00485	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00086	0.00462	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000823	0.00442	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000819	0.0044	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000804	0.00432	CbGpPWpGaD
Rufinamide—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000803	0.00185	CcSEcCtD
Rufinamide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.0008	0.00185	CcSEcCtD
Rufinamide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0008	0.00185	CcSEcCtD
Rufinamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000799	0.00184	CcSEcCtD
Rufinamide—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000798	0.00184	CcSEcCtD
Rufinamide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000794	0.00183	CcSEcCtD
Rufinamide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000794	0.00183	CcSEcCtD
Rufinamide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000793	0.00183	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000789	0.00423	CbGpPWpGaD
Rufinamide—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.00182	CcSEcCtD
Rufinamide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000788	0.00182	CcSEcCtD
Rufinamide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000783	0.00181	CcSEcCtD
Rufinamide—Infection—Vincristine—peripheral nervous system neoplasm	0.000781	0.0018	CcSEcCtD
Rufinamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000779	0.0018	CcSEcCtD
Rufinamide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000778	0.00179	CcSEcCtD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000776	0.00417	CbGpPWpGaD
Rufinamide—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000773	0.00178	CcSEcCtD
Rufinamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000773	0.00178	CcSEcCtD
Rufinamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000773	0.00178	CcSEcCtD
Rufinamide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000771	0.00178	CcSEcCtD
Rufinamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00077	0.00178	CcSEcCtD
Rufinamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00077	0.00413	CbGpPWpGaD
Rufinamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000768	0.00177	CcSEcCtD
Rufinamide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.00177	CcSEcCtD
Rufinamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000763	0.00176	CcSEcCtD
Rufinamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000763	0.00176	CcSEcCtD
Rufinamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000762	0.00176	CcSEcCtD
Rufinamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000762	0.00176	CcSEcCtD
Rufinamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000759	0.00175	CcSEcCtD
Rufinamide—Back pain—Etoposide—peripheral nervous system neoplasm	0.000755	0.00174	CcSEcCtD
Rufinamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000752	0.00173	CcSEcCtD
Rufinamide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00075	0.00173	CcSEcCtD
Rufinamide—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000743	0.00399	CbGpPWpGaD
Rufinamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000743	0.00171	CcSEcCtD
Rufinamide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000738	0.0017	CcSEcCtD
Rufinamide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000738	0.0017	CcSEcCtD
Rufinamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000737	0.0017	CcSEcCtD
Rufinamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000737	0.0017	CcSEcCtD
Rufinamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000727	0.00168	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000727	0.00168	CcSEcCtD
Rufinamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000726	0.00167	CcSEcCtD
Rufinamide—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000723	0.00167	CcSEcCtD
Rufinamide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000722	0.00166	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00072	0.00166	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00072	0.00387	CbGpPWpGaD
Rufinamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000719	0.00166	CcSEcCtD
Rufinamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000718	0.00166	CcSEcCtD
Rufinamide—SCN11A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000717	0.00385	CbGpPWpGaD
Rufinamide—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000716	0.00165	CcSEcCtD
Rufinamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000712	0.00164	CcSEcCtD
Rufinamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000712	0.00164	CcSEcCtD
Rufinamide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000711	0.00164	CcSEcCtD
Rufinamide—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000711	0.00382	CbGpPWpGaD
Rufinamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.00164	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000706	0.00379	CbGpPWpGaD
Rufinamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000705	0.00163	CcSEcCtD
Rufinamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000704	0.00162	CcSEcCtD
Rufinamide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000701	0.00162	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000699	0.00161	CcSEcCtD
Rufinamide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.00161	CcSEcCtD
Rufinamide—Infection—Cisplatin—peripheral nervous system neoplasm	0.000691	0.00159	CcSEcCtD
Rufinamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00069	0.00159	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000686	0.00369	CbGpPWpGaD
Rufinamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000685	0.00158	CcSEcCtD
Rufinamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000685	0.00158	CcSEcCtD
Rufinamide—Rash—Topotecan—peripheral nervous system neoplasm	0.000685	0.00158	CcSEcCtD
Rufinamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000684	0.00158	CcSEcCtD
Rufinamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000684	0.00158	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000683	0.00158	CcSEcCtD
Rufinamide—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000683	0.00367	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000683	0.00367	CbGpPWpGaD
Rufinamide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000682	0.00157	CcSEcCtD
Rufinamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000681	0.00157	CcSEcCtD
Rufinamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00068	0.00157	CcSEcCtD
Rufinamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000679	0.00157	CcSEcCtD
Rufinamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000679	0.00157	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000679	0.00157	CcSEcCtD
Rufinamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000678	0.00157	CcSEcCtD
Rufinamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000678	0.00157	CcSEcCtD
Rufinamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000678	0.00156	CcSEcCtD
Rufinamide—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000677	0.00363	CbGpPWpGaD
Rufinamide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000676	0.00156	CcSEcCtD
Rufinamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000676	0.00156	CcSEcCtD
Rufinamide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000676	0.00156	CcSEcCtD
Rufinamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000675	0.00156	CcSEcCtD
Rufinamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000675	0.00156	CcSEcCtD
Rufinamide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000673	0.00155	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000672	0.00155	CcSEcCtD
Rufinamide—Rash—Melphalan—peripheral nervous system neoplasm	0.00067	0.00155	CcSEcCtD
Rufinamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00067	0.00154	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00153	CcSEcCtD
Rufinamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000663	0.00153	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00066	0.00152	CcSEcCtD
Rufinamide—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000659	0.00354	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000659	0.00354	CbGpPWpGaD
Rufinamide—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000657	0.00151	CcSEcCtD
Rufinamide—SCN8A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000656	0.00352	CbGpPWpGaD
Rufinamide—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00065	0.0015	CcSEcCtD
Rufinamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000649	0.0015	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000647	0.00348	CbGpPWpGaD
Rufinamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000645	0.00149	CcSEcCtD
Rufinamide—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000641	0.00414	CbGeAlD
Rufinamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00064	0.00148	CcSEcCtD
Rufinamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00064	0.00148	CcSEcCtD
Rufinamide—Infection—Etoposide—peripheral nervous system neoplasm	0.000633	0.00146	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.00146	CcSEcCtD
Rufinamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000632	0.00146	CcSEcCtD
Rufinamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000631	0.00146	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00063	0.00338	CbGpPWpGaD
Rufinamide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000628	0.00145	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000624	0.00144	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000623	0.00335	CbGpPWpGaD
Rufinamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000622	0.00334	CbGpPWpGaD
Rufinamide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000619	0.00143	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.00142	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.0014	CcSEcCtD
Rufinamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000607	0.0014	CcSEcCtD
Rufinamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000605	0.00139	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000604	0.00139	CcSEcCtD
Rufinamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000602	0.00139	CcSEcCtD
Rufinamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.00139	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.00139	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.0006	0.00139	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00135	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00135	CcSEcCtD
Rufinamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000586	0.00135	CcSEcCtD
Rufinamide—CES1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000583	0.00313	CbGpPWpGaD
Rufinamide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.00134	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00058	0.00134	CcSEcCtD
Rufinamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000579	0.00134	CcSEcCtD
Rufinamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000577	0.00133	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000575	0.00309	CbGpPWpGaD
Rufinamide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000568	0.00131	CcSEcCtD
Rufinamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000566	0.00131	CcSEcCtD
Rufinamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000564	0.0013	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000563	0.0013	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00129	CcSEcCtD
Rufinamide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00129	CcSEcCtD
Rufinamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00056	0.00129	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.00129	CcSEcCtD
Rufinamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.00129	CcSEcCtD
Rufinamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000555	0.00128	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000554	0.00128	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00055	0.00127	CcSEcCtD
Rufinamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000549	0.00127	CcSEcCtD
Rufinamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000545	0.00126	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.00125	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.00125	CcSEcCtD
Rufinamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.00125	CcSEcCtD
Rufinamide—SCN7A—Axon guidance—MET—peripheral nervous system neoplasm	0.000539	0.00289	CbGpPWpGaD
Rufinamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000538	0.00124	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.00124	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000534	0.00123	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00053	0.00285	CbGpPWpGaD
Rufinamide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00053	0.00122	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000528	0.00122	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000527	0.00283	CbGpPWpGaD
Rufinamide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.00121	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00121	CcSEcCtD
Rufinamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000523	0.00121	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000521	0.0012	CcSEcCtD
Rufinamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00052	0.0012	CcSEcCtD
Rufinamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.0012	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.0012	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.0012	CcSEcCtD
Rufinamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.00119	CcSEcCtD
Rufinamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000514	0.00119	CcSEcCtD
Rufinamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000512	0.00118	CcSEcCtD
Rufinamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000511	0.00118	CcSEcCtD
Rufinamide—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000507	0.00272	CbGpPWpGaD
Rufinamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000504	0.00116	CcSEcCtD
Rufinamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.0005	0.00115	CcSEcCtD
Rufinamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000499	0.00115	CcSEcCtD
Rufinamide—SCN7A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000498	0.00268	CbGpPWpGaD
Rufinamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000496	0.00115	CcSEcCtD
Rufinamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000496	0.00114	CcSEcCtD
Rufinamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000495	0.00114	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.00114	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000493	0.00114	CcSEcCtD
Rufinamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000493	0.00114	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.00113	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00113	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000487	0.00262	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000487	0.00262	CbGpPWpGaD
Rufinamide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.00112	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000486	0.00261	CbGpPWpGaD
Rufinamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.00112	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—MET—peripheral nervous system neoplasm	0.00048	0.00258	CbGpPWpGaD
Rufinamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000476	0.0011	CcSEcCtD
Rufinamide—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00047	0.00252	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00047	0.00252	CbGpPWpGaD
Rufinamide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00108	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000469	0.00108	CcSEcCtD
Rufinamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000467	0.00108	CcSEcCtD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000467	0.00251	CbGpPWpGaD
Rufinamide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000467	0.00108	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.00108	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000466	0.0025	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000463	0.00249	CbGpPWpGaD
Rufinamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.00106	CcSEcCtD
Rufinamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000457	0.00105	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00105	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000454	0.00105	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000453	0.00105	CcSEcCtD
Rufinamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000451	0.00104	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000444	0.00239	CbGpPWpGaD
Rufinamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000442	0.00102	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00102	CcSEcCtD
Rufinamide—SCN8A—Axon guidance—MET—peripheral nervous system neoplasm	0.000439	0.00236	CbGpPWpGaD
Rufinamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000439	0.00101	CcSEcCtD
Rufinamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000438	0.00101	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000438	0.00101	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000436	0.00101	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.001	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000996	CcSEcCtD
Rufinamide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000976	CcSEcCtD
Rufinamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000421	0.000972	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000969	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000967	CcSEcCtD
Rufinamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000413	0.000953	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000951	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00094	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000407	0.00219	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000406	0.00218	CbGpPWpGaD
Rufinamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000405	0.000934	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000934	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000933	CcSEcCtD
Rufinamide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000928	CcSEcCtD
Rufinamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000402	0.000927	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000401	0.000926	CcSEcCtD
Rufinamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000399	0.000921	CcSEcCtD
Rufinamide—SCN7A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000394	0.00211	CbGpPWpGaD
Rufinamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000907	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000904	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000903	CcSEcCtD
Rufinamide—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000389	0.00209	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000384	0.00206	CbGpPWpGaD
Rufinamide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00088	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000875	CcSEcCtD
Rufinamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000378	0.000873	CcSEcCtD
Rufinamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000375	0.00201	CbGpPWpGaD
Rufinamide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000863	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000858	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000856	CcSEcCtD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00037	0.00199	CbGpPWpGaD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000853	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00037	0.00198	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000368	0.00198	CbGpPWpGaD
Rufinamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000839	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000836	CcSEcCtD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000357	0.00192	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000356	0.00191	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000356	0.00191	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000355	0.00191	CbGpPWpGaD
Rufinamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000818	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000351	0.00188	CbGpPWpGaD
Rufinamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000809	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000808	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000807	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000347	0.0008	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000792	CcSEcCtD
Rufinamide—SCN11A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000343	0.00184	CbGpPWpGaD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00079	CcSEcCtD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000341	0.00183	CbGpPWpGaD
Rufinamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000785	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00034	0.00183	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.00034	0.00182	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00033	0.00177	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000329	0.00176	CbGpPWpGaD
Rufinamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000757	CcSEcCtD
Rufinamide—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.000326	0.00175	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.000326	0.00175	CbGpPWpGaD
Rufinamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000748	CcSEcCtD
Rufinamide—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000324	0.00174	CbGpPWpGaD
Rufinamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000746	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000323	0.00174	CbGpPWpGaD
Rufinamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000745	CcSEcCtD
Rufinamide—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000321	0.00172	CbGpPWpGaD
Rufinamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.00074	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000732	CcSEcCtD
Rufinamide—SCN11A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000317	0.0017	CbGpPWpGaD
Rufinamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000727	CcSEcCtD
Rufinamide—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000315	0.00169	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000315	0.00169	CbGpPWpGaD
Rufinamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000725	CcSEcCtD
Rufinamide—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000314	0.00169	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000313	0.00168	CbGpPWpGaD
Rufinamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000716	CcSEcCtD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000309	0.00166	CbGpPWpGaD
Rufinamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000711	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00071	CcSEcCtD
Rufinamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000705	CcSEcCtD
Rufinamide—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000302	0.00162	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000302	0.00162	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.0003	0.00161	CbGpPWpGaD
Rufinamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000689	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000678	CcSEcCtD
Rufinamide—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000291	0.00156	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000291	0.00156	CbGpPWpGaD
Rufinamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000671	CcSEcCtD
Rufinamide—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00029	0.00156	CbGpPWpGaD
Rufinamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000663	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000658	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000657	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000652	CcSEcCtD
Rufinamide—SCN7A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000281	0.00151	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000267	0.00143	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000263	0.00141	CbGpPWpGaD
Rufinamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000607	CcSEcCtD
Rufinamide—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00026	0.00139	CbGpPWpGaD
Rufinamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000591	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000255	0.00137	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000253	0.00136	CbGpPWpGaD
Rufinamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000583	CcSEcCtD
Rufinamide—SCN11A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00025	0.00135	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000249	0.00134	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000248	0.00133	CbGpPWpGaD
Rufinamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000564	CcSEcCtD
Rufinamide—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000244	0.00131	CbGpPWpGaD
Rufinamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000562	CcSEcCtD
Rufinamide—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000242	0.0013	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000239	0.00128	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000239	0.00128	CbGpPWpGaD
Rufinamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000547	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000545	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000234	0.00126	CbGpPWpGaD
Rufinamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000539	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000233	0.00125	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000233	0.00125	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00023	0.00124	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00023	0.00124	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000229	0.00123	CbGpPWpGaD
Rufinamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000524	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000522	CcSEcCtD
Rufinamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000519	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000519	CcSEcCtD
Rufinamide—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000225	0.00121	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000225	0.00121	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000225	0.00121	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000224	0.0012	CbGpPWpGaD
Rufinamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000516	CcSEcCtD
Rufinamide—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000221	0.00119	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000219	0.00118	CbGpPWpGaD
Rufinamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000504	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000218	0.00117	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000215	0.00116	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000215	0.00116	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000214	0.00115	CbGpPWpGaD
Rufinamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000489	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000485	CcSEcCtD
Rufinamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000481	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00048	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000208	0.00112	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000208	0.00112	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000208	0.00112	CbGpPWpGaD
Rufinamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000478	CcSEcCtD
Rufinamide—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000205	0.0011	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000198	0.00106	CbGpPWpGaD
Rufinamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000453	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000195	0.00105	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000191	0.00103	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000191	0.00103	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000191	0.00102	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000189	0.00101	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000185	0.000995	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000182	0.000975	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000182	0.000975	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000179	0.00096	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000177	0.000952	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000175	0.00094	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000175	0.00094	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000174	0.000936	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000173	0.000926	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00017	0.000914	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00017	0.000914	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000165	0.000884	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000164	0.000882	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000164	0.000882	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000164	0.000882	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000162	0.000869	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000158	0.000849	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000158	0.000848	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000156	0.00084	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000148	0.000795	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000146	0.000784	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000145	0.000776	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000144	0.000772	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000141	0.000757	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000139	0.000749	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000138	0.000742	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000138	0.000742	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000135	0.000725	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000135	0.000724	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000133	0.000713	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000133	0.000713	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000133	0.000713	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00013	0.000696	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00013	0.000696	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000129	0.000693	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000128	0.000688	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000128	0.000688	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000128	0.000685	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000127	0.000681	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000125	0.000671	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000125	0.000671	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000123	0.000661	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000123	0.000661	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000115	0.00062	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000113	0.000605	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000111	0.000596	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000105	0.000563	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000103	0.000554	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.88e-05	0.000531	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.86e-05	0.00053	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.61e-05	0.000516	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	9.59e-05	0.000515	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.52e-05	0.000511	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.48e-05	0.000509	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.48e-05	0.000509	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	9.34e-05	0.000501	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.22e-05	0.000495	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.14e-05	0.000491	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.14e-05	0.000491	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.11e-05	0.000489	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	9e-05	0.000483	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	8.95e-05	0.000481	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	8.89e-05	0.000478	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.87e-05	0.000476	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.78e-05	0.000472	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.72e-05	0.000468	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.71e-05	0.000468	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	8.62e-05	0.000463	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.37e-05	0.000449	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.37e-05	0.000449	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.37e-05	0.000449	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.07e-05	0.000433	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.07e-05	0.000433	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNS—peripheral nervous system neoplasm	8.02e-05	0.000431	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.98e-05	0.000428	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	7.78e-05	0.000418	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NME1—peripheral nervous system neoplasm	7.69e-05	0.000413	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.43e-05	0.000399	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	7.41e-05	0.000398	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COX2—peripheral nervous system neoplasm	7.4e-05	0.000398	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.73e-05	0.000361	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.6e-05	0.000355	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.42e-05	0.000345	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.1e-05	0.000328	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.99e-05	0.000322	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.84e-05	0.000313	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.67e-05	0.000305	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	5.66e-05	0.000304	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	5.4e-05	0.00029	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.15e-05	0.000277	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	4.86e-05	0.000261	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	4.78e-05	0.000257	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.56e-05	0.000245	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	4.49e-05	0.000241	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.33e-05	0.000233	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.15e-05	0.000223	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	4.11e-05	0.000221	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.07e-05	0.000219	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4e-05	0.000215	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.92e-05	0.00021	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TH—peripheral nervous system neoplasm	3.86e-05	0.000207	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	3.67e-05	0.000197	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.6e-05	0.000193	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	3.25e-05	0.000174	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	3.15e-05	0.000169	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	3.09e-05	0.000166	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.62e-05	0.000141	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	2.49e-05	0.000133	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.38e-05	0.000128	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.22e-05	0.000119	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.12e-05	0.000114	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	2.1e-05	0.000113	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.08e-05	0.000112	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.7e-05	9.14e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.67e-05	8.97e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	9.9e-06	5.32e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	8.51e-06	4.57e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.59e-06	2.47e-05	CbGpPWpGaD
